COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production
Emmanuel Lamptey, Ephraim Kumi Senkyire, Dooshima Aki Benita, Evans Osei Boakye
Abstract
Following the development of the coronavirus disease 2019 (COVID-19) vaccines and the launching of vaccination, the World Health Organization has reported that the African Continent is lagging in the race to vaccinate its population against the deadly virus. The Continent has received a limited number of vaccines, implying that vaccine production needs to be scaled up in Africa. In this review, we summarize the current situation concerning COVID-19 vaccine development in Africa, progress made, challenges faced in vaccine development over the years and potential strategies that will harness vaccine production success.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineLaggingVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyPopulation2019-20 coronavirus outbreakEconomic growthEnvironmental healthOutbreakDiseaseInfectious disease (medical specialty)EconomicsPathologySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancyvaccines and immunoinformatics approaches